FierceBiotechFierceBiotechResearchFierceBiotechITFierceVaccinesFiercePharmaFiercePharmaManufacturing   FierceHealthcare
Syndicate content

Japan related Press Releases

Celgene Announces New Drug Application Filing for REVLIMID in Japan

Posted July 7, 2009

Celgene Announces New Drug Application Filing for REVLIMID® in Japan REVLIMID filing based on safety and efficacy results of two large, randomised pivotal Phase III trials, as well as specific... Read more...

Shire Announces Opening of Office in Japan

Posted February 20, 2009

Shire Announces Opening of Office in Japan TOKYO, Japan and CAMBRIDGE, Massachusetts, February 20 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty... Read more...

Bristol-Myers Squibb and AstraZeneca Announce Expansion of Worldwide Collaboration to Develop and Commercialize Dapagliflozin

Posted December 8, 2008

Bristol-Myers Squibb and AstraZeneca Announce Expansion of Worldwide Collaboration to Develop and Commercialize Dapagliflozin in Japan PRINCETON, N.J. & LONDON--(BUSINESS WIRE)--Bristol-Myers

... Read more...

Sanofi Pasteur First International Vaccine Company to Enter Japan With Pediatric Vaccine ActHIB (Haemophilus Influenzae Type b)

Posted November 10, 2008

Sanofi Pasteur First International Vaccine Company to Enter Japan With Pediatric Vaccine ActHIB (Haemophilus Influenzae Type b Vaccine) Available in Japan on December 19, 2008 LYON, France, November

... Read more...

MedImmune Licenses Reverse Genetics Technology to Japan's BIKEN for Use in Influenza Vaccine Development and Production

Posted September 30, 2008

MedImmune Licenses Reverse Genetics Technology to Japan's BIKEN for Use in Influenza Vaccine Development and Production GAITHERSBURG, Md., Sept 29, 2008 /PRNewswire via COMTEX News Network/ --... Read more...

Merck & Co., Inc. (MRK) (JOBS), Japan Tobacco in Osteoporosis Drug Deal

Posted September 25, 2008

Merck & Co., Inc. (MRK) (JOBS), Japan Tobacco in Osteoporosis Drug Deal September 25, 2008 WHITEHOUSE STATION, N.J. & TOKYO--(BUSINESS WIRE)--Merck & Co., Inc. and Japan Tobacco Inc. (JT)... Read more...

Teva and Kowa Announce Strategic Partnership to Create a Leading Generic Pharmaceutical Company in Japan

Posted September 24, 2008

Teva and Kowa Announce Strategic Partnership to Create a Leading Generic Pharmaceutical Company in Japan Goal to Reach Sales of $1 Billion in 2015 Jerusalem, Israel, and Tokyo, Japan, September 24,... Read more...